Absci (ABSI) Amortization of Goodwill (2023)

Absci (ABSI) reported Amortization of Goodwill of $21.3 million for Q2 2023.

Absci (ABSI) Amortization of Goodwill (2023) Analysis & Trends

Absci (ABSI) has 1 years of Amortization of Goodwill data on file, last reported at $21.3 million in Q2 2023.

For the quarter ending Q2 2023, Amortization of Goodwill changed N/A year-over-year to $21.3 million; the trailing twelve-month figure through Jun 2024 stood at $21.3 million (changed 0.0% YoY), and the FY2023 full-year result was $21.3 million, changed N/A from the prior year.
Amortization of Goodwill was little changed at $21.3 million in Q2 2023.
In the past five years, Amortization of Goodwill ranged from a high of $21.3 million in Q2 2023 to a low of $21.3 million in Q2 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn
4	NuCana	279.75 Bn	279.75 Bn	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn
7	Belite Bio	62.51 Bn	62.51 Bn	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn
9	Revolution Medicines	37.78 Bn	37.78 Bn	-
10	Absci	1.23 Bn	1.11 Bn	-

Download Data

Date	Value
Jun 30, 2023	21.30 Mn
Jun 30, 2023	21.30 Mn